These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11509956)

  • 1. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
    Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
    Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
    Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
    Lucas ML; Heller L; Coppola D; Heller R
    Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.
    Kishida T; Asada H; Itokawa Y; Yasutomi K; Shin-Ya M; Gojo S; Cui FD; Ueda Y; Yamagishi H; Imanishi J; Mazda O
    Mol Ther; 2003 Nov; 8(5):738-45. PubMed ID: 14599806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.
    Wang Q; Yu H; Ju DW; He L; Pan JP; Xia DJ; Zhang LH; Cao X
    Gene Ther; 2001 Apr; 8(7):542-50. PubMed ID: 11319621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
    Lucas ML; Heller R
    DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective transfer of interleukin-12 gene to solid tumors using a novel gene delivery system, poly [D,L-2,4-diaminobutyric acid].
    Iwashita Y; Ogawa T; Goto S; Nakanishi M; Goto T; Kitano S
    Cancer Gene Ther; 2004 Feb; 11(2):103-8. PubMed ID: 14671674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
    Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
    Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity.
    Ju DW; Yang Y; Tao Q; Song WG; He L; Chen G; Gu S; Ting CC; Cao X
    Gene Ther; 2000 Oct; 7(19):1672-9. PubMed ID: 11083476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters.
    Burkart C; Mukhopadhyay A; Shirley SA; Connolly RJ; Wright JH; Bahrami A; Campbell JS; Pierce RH; Canton DA
    Gene Ther; 2018 Apr; 25(2):93-103. PubMed ID: 29523878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of interleukin 12 to antitumor cytokine and gene therapy.
    Nishimura T; Watanabe K; Yahata T; Ushaku L; Ando K; Kimura M; Saiki I; Uede T; Habu S
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S27-34. PubMed ID: 8765412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα.
    Choi IK; Lee JS; Zhang SN; Park J; Sonn CH; Lee KM; Yun CO
    Gene Ther; 2011 Sep; 18(9):898-909. PubMed ID: 21451575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
    Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O
    J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model.
    Yamashita YI; Shimada M; Hasegawa H; Minagawa R; Rikimaru T; Hamatsu T; Tanaka S; Shirabe K; Miyazaki JI; Sugimachi K
    Cancer Res; 2001 Feb; 61(3):1005-12. PubMed ID: 11221826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
    Marchi LH; Paschoalin T; Travassos LR; Rodrigues EG
    Cancer Gene Ther; 2011 Feb; 18(2):110-22. PubMed ID: 20885448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
    Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
    J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism.
    Kim H; Sin JI
    Hum Vaccin Immunother; 2012 Nov; 8(11):1714-21. PubMed ID: 23151450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer.
    Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T
    Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antitumor immunity and treatment of preestablished tumor by interleukin-6-gene-transfected melanoma cells combined with low-dose interleukin-2.
    Cao X; Zhang W; Gu S; Yu Y; Tao Q; Ye T
    J Cancer Res Clin Oncol; 1995; 121(12):721-8. PubMed ID: 7499443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.